Quinidine Monosulfate 是一种抗心律失常剂。Quinidine Monosulfate 是一种有效的、具有口服活性的、选择性的细胞色素 P450db (cytochrome P450db) 抑制剂,也是 K+通道 (K+channel) 的有效阻断剂,其IC50值为 19.9 μM,也可诱导凋亡。Quinidine Monosulfate 也可用作疟疾的研究。
生物活性 | Quinidine Monosulfate is an antiarrhythmic agent. Quinidine Monosulfate is a potent, orally active, selectivecytochrome P450dbinhibitor. Quinidine Monosulfate is also aK+channelblocker with anIC50of 19.9 μM, and can induceapoptosis. Quinidine Monosulfate can be used for malaria research[1][2][3][4]. |
体外研究 (In Vitro) | Quinidine Monosulfate shows cytotoxicity against MES-SA cells, and induces apoptosis[4].
Cell Cytotoxicity Assay[4] Cell Line: | MES-SA and MESSA/DX5 cells | Concentration: | 10 μM | Incubation Time: | 24 hours | Result: | Showed cytotoxicity against MES-SA cells in a concentration-dependent manner. |
Apoptosis Analysis[4] Cell Line: | MES-SA and MESSA/DX5 cells | Concentration: | 10 μM | Incubation Time: | 24 hours | Result: | Increased the apoptotic portion sub-G1 DNA contents induced by paclitaxel, while paclitaxel had no effect on sub-G1 DNA contents undergoing apoptosis. |
|
体内研究 (In Vivo) | Quinidine Monosulfate shows effects on the PTZ-induced seizure threshold[5].
Animal Model: | Male mice of the NMRI strain (age 5-6 weeks and weight 25-30 g)[5] | Dosage: | 10, 20, and 30 mg/kg | Administration: | Intraperitoneal injection; 10, 20, and 30 mg/kg; once | Result: | Increased the threshold dose for the onset to tonic hind limb extension at a dose of 30 mg/kg, compared to the saline-treated control group (p<0.05). |
|
Clinical Trial | |
分子量 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |